AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., an oncology molecular diagnostic company and molecular biology service provider, announced today it was selected to provide GLP compliant laboratory testing to assist in gene expression studies being conducted by Millennium Pharmaceuticals of Cambridge, MA.
